2',3'-cGAMP

cyclic-[G(2',5')pA(3',5')p]

Cyclic-(guanosine-(2'→5')-monophosphate-adenosine-(3'→5')-monophosphate), Sodium salt

Catálogo Nº Apresentação Preço (R$) Comprar
NU-249S 1 μmolSob demanda Adicionar ao Carrinho
NU-249L 5 x 1 μmolSob demanda Adicionar ao Carrinho
Structural formula of 2',3'-cGAMP (cyclic-[G(2',5')pA(3',5')p], Cyclic-(guanosine-(2'→5')-monophosphate-adenosine-(3'→5')-monophosphate), Sodium salt)
Structural formula of 2',3'-cGAMP

For general laboratory use.

Envio: shipped on gel packs

Condições de armazenamento: store at -20 °C
Short term exposure (up to 1 week cumulative) to ambient temperature possible.

Validade: 12 months after date of delivery

Fórmula molecular: C20H24N10O13P2 (free acid)

Peso molecular: 674.42 g/mol (free acid)

Pureza: ≥ 95 % (HPLC)

Forma: solid

Propriedades espectroscópicas: λmax 260 nm, ε 25.0 L mmol-1 cm-1 (Tris-HCl pH 7.5)

Referências selecionadas:
Li et al. (2018) The cGAS–cGAMP–STING pathway connects DNA damage to inflammation, senescence, and cancer. J. Exp. Med. 215 (5):1287.

Li et al. (2016) Antitumor activity of cGAMP via stimulation of cGAS-cGAMP-STING-IRF3 mediated innate immune response. Nature Scientific Reports 6:19049.

Tao et al. (2016) cGAS-cGAMP-STING: The three musketeers of cytosolic DNA sensing and signaling. IUBMB Life 68 (11):858.

Temizoz et al. (2015) TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN. Eur. J. Immunol. 45:1159.